{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:09:10Z","timestamp":1795007350828,"version":"4.9.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T00:00:00Z","timestamp":1662595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["108070\/Z\/15\/Z"],"award-info":[{"award-number":["108070\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207503\/Z\/17\/Z"],"award-info":[{"award-number":["207503\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L018942\/1"],"award-info":[{"award-number":["MR\/L018942\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2018-I2M-2-002"],"award-info":[{"award-number":["2018-I2M-2-002"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interferon-induced transmembrane protein 3 (IFITM3) is a restriction factor that limits viral pathogenesis and exerts poorly understood immunoregulatory functions. Here, using human and mouse models, we demonstrate that IFITM3 promotes MyD88-dependent, TLR-mediated IL-6 production following exposure to cytomegalovirus (CMV). IFITM3 also restricts IL-6 production in response to influenza and SARS-CoV-2. In dendritic cells, IFITM3 binds to the reticulon 4 isoform Nogo-B and promotes its proteasomal degradation. We reveal that Nogo-B mediates TLR-dependent pro-inflammatory cytokine production and promotes viral pathogenesis in vivo, and in the case of TLR2 responses, this process involves alteration of TLR2 cellular localization. Nogo-B deletion abrogates inflammatory cytokine responses and associated disease in virus-infected IFITM3-deficient mice. Thus, we uncover Nogo-B as a driver of viral pathogenesis and highlight an immunoregulatory pathway in which IFITM3 fine-tunes the responsiveness of myeloid cells to viral stimulation.<\/jats:p>","DOI":"10.1038\/s41467-022-32587-4","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:09:57Z","timestamp":1662649797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["IFITM3 restricts virus-induced inflammatory cytokine production by limiting Nogo-B mediated TLR responses"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9280-5281","authenticated-orcid":false,"given":"M.","family":"Clement","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Forbester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Marsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Sabberwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Sommerville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9277-0306","authenticated-orcid":false,"given":"D.","family":"Wellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Dimonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Harcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2044-5838","authenticated-orcid":false,"given":"Z.","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Antrobus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Makvandi-Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Lindborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8188-3092","authenticated-orcid":false,"given":"S. M.","family":"Strittmatter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3196-5545","authenticated-orcid":false,"given":"M. P.","family":"Weekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6799-1182","authenticated-orcid":false,"given":"R. J.","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9512-5337","authenticated-orcid":false,"given":"I. R.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,8]]},"reference":[{"key":"32587_CR1","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature10921","volume":"484","author":"AR Everitt","year":"2012","unstructured":"Everitt, A. R. et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484, 519\u2013523 (2012).","journal-title":"Nature"},{"key":"32587_CR2","doi-asserted-by":"publisher","first-page":"12646","DOI":"10.1128\/JVI.01328-10","volume":"84","author":"JM Weidner","year":"2010","unstructured":"Weidner, J. M. et al. Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84, 12646\u201312657 (2010).","journal-title":"J. Virol."},{"key":"32587_CR3","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1128\/JVI.01531-10","volume":"85","author":"J Lu","year":"2011","unstructured":"Lu, J. et al. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126\u20132137 (2011).","journal-title":"J. Virol."},{"key":"32587_CR4","doi-asserted-by":"publisher","first-page":"e1001258","DOI":"10.1371\/journal.ppat.1001258","volume":"7","author":"IC Huang","year":"2011","unstructured":"Huang, I. C. et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7, e1001258 (2011).","journal-title":"PLoS Pathog."},{"key":"32587_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.celrep.2013.10.033","volume":"5","author":"TY Lin","year":"2013","unstructured":"Lin, T. Y. et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 5, 895\u2013908 (2013).","journal-title":"Cell Rep."},{"key":"32587_CR6","doi-asserted-by":"publisher","first-page":"e1003124","DOI":"10.1371\/journal.ppat.1003124","volume":"9","author":"K Li","year":"2013","unstructured":"Li, K. et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog. 9, e1003124 (2013).","journal-title":"PLoS Pathog."},{"key":"32587_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.chom.2013.03.006","volume":"13","author":"S Amini-Bavil-Olyaee","year":"2013","unstructured":"Amini-Bavil-Olyaee, S. et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe 13, 452\u2013464 (2013).","journal-title":"Cell Host Microbe"},{"key":"32587_CR8","doi-asserted-by":"publisher","first-page":"e1004048","DOI":"10.1371\/journal.ppat.1004048","volume":"10","author":"TM Desai","year":"2014","unstructured":"Desai, T. M. et al. IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog. 10, e1004048 (2014).","journal-title":"PLoS Pathog."},{"key":"32587_CR9","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.3390\/v6093683","volume":"6","author":"F Wrensch","year":"2014","unstructured":"Wrensch, F., Winkler, M. & P\u00f6hlmann, S. IFITM proteins inhibit entry driven by the MERS-coronavirus spike protein: evidence for cholesterol-independent mechanisms. Viruses 6, 3683\u20133698 (2014).","journal-title":"Viruses"},{"key":"32587_CR10","doi-asserted-by":"publisher","first-page":"e1007532","DOI":"10.1371\/journal.ppat.1007532","volume":"15","author":"KC Suddala","year":"2019","unstructured":"Suddala, K. C. et al. Interferon-induced transmembrane protein 3 blocks fusion of sensitive but not resistant viruses by partitioning into virus-carrying endosomes. PLoS Pathog. 15, e1007532 (2019).","journal-title":"PLoS Pathog."},{"key":"32587_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41589-018-0213-2","volume":"15","author":"JS Spence","year":"2019","unstructured":"Spence, J. S. et al. IFITM3 directly engages and shuttles incoming virus particles to lysosomes. Nat. Chem. Biol. 15, 259\u2013268 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"32587_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.celrep.2015.08.055","volume":"13","author":"J Yu","year":"2015","unstructured":"Yu, J. et al. IFITM proteins restrict HIV-1 infection by antagonizing the envelope glycoprotein. Cell Rep. 13, 145\u2013156 (2015).","journal-title":"Cell Rep."},{"key":"32587_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.bj.2019.01.004","volume":"42","author":"D Wellington","year":"2019","unstructured":"Wellington, D., Laurenson-Schafer, H., Abdel-Haq, A. & Dong, T. IFITM3: how genetics influence influenza infection demographically. Biomed. J. 42, 19\u201326 (2019).","journal-title":"Biomed. J."},{"key":"32587_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiaa224","volume":"222","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Interferon-induced transmembrane protein 3 genetic variant rs12252-C associated with disease severity in Coronavirus Disease 2019. J. Infect. Dis. 222, 34\u201337 (2020).","journal-title":"J. Infect. Dis."},{"key":"32587_CR15","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nm.4370","volume":"23","author":"EK Allen","year":"2017","unstructured":"Allen, E. K. et al. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans. Nat. Med. 23, 975\u2013983 (2017).","journal-title":"Nat. Med."},{"key":"32587_CR16","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/infdis\/jix512","volume":"217","author":"S Makvandi-Nejad","year":"2018","unstructured":"Makvandi-Nejad, S. et al. Lack of truncated IFITM3 transcripts in cells homozygous for the rs12252-C variant that is associated with severe influenza infection. J. Infect. Dis. 217, 257\u2013262 (2018).","journal-title":"J. Infect. Dis."},{"key":"32587_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2433","volume":"4","author":"YH Zhang","year":"2013","unstructured":"Zhang, Y. H. et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat. Commun. 4, 1418 (2013).","journal-title":"Nat. Commun."},{"key":"32587_CR18","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1073\/pnas.1321748111","volume":"111","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc. Natl Acad. Sci. USA 111, 769\u2013774 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32587_CR19","doi-asserted-by":"publisher","first-page":"8780","DOI":"10.1128\/JVI.00655-16","volume":"90","author":"S Poddar","year":"2016","unstructured":"Poddar, S., Hyde, J. L., Gorman, M. J., Farzan, M. & Diamond, M. S. The interferon-stimulated gene IFITM3 restricts infection and pathogenesis of arthritogenic and encephalitic alphaviruses. J. Virol. 90, 8780\u20138794 (2016).","journal-title":"J. Virol."},{"key":"32587_CR20","doi-asserted-by":"publisher","first-page":"e80723","DOI":"10.1371\/journal.pone.0080723","volume":"8","author":"AR Everitt","year":"2013","unstructured":"Everitt, A. R. et al. Defining the range of pathogens susceptible to Ifitm3 restriction using a knockout mouse model. PLoS ONE 8, e80723 (2013).","journal-title":"PLoS ONE"},{"key":"32587_CR21","doi-asserted-by":"publisher","first-page":"8212","DOI":"10.1128\/JVI.00581-16","volume":"90","author":"MJ Gorman","year":"2016","unstructured":"Gorman, M. J., Poddar, S., Farzan, M. & Diamond, M. S. The interferon-stimulated gene Ifitm3 restricts West Nile Virus infection and pathogenesis. J. Virol. 90, 8212\u20138225 (2016).","journal-title":"J. Virol."},{"key":"32587_CR22","doi-asserted-by":"publisher","first-page":"18607","DOI":"10.1073\/pnas.1900784116","volume":"116","author":"AD Kenney","year":"2019","unstructured":"Kenney, A. D. et al. IFITM3 protects the heart during influenza virus infection. Proc. Natl Acad. Sci. USA 116, 18607\u201318612 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32587_CR23","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/JCI84889","volume":"127","author":"MA Stacey","year":"2017","unstructured":"Stacey, M. A. et al. The antiviral restriction factor IFN-induced transmembrane protein 3 prevents cytokine-driven CMV pathogenesis. J. Clin. Invest. 127, 1463\u20131474 (2017).","journal-title":"J. Clin. Invest."},{"key":"32587_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/cmi.2017.15","volume":"15","author":"LQ Jiang","year":"2018","unstructured":"Jiang, L. Q. et al. IFITM3 inhibits virus-triggered induction of type I interferon by mediating autophagosome-dependent degradation of IRF3. Cell Mol. Immunol. 15, 858\u2013867 (2018).","journal-title":"Cell Mol. Immunol."},{"key":"32587_CR25","doi-asserted-by":"publisher","first-page":"e0184568","DOI":"10.1371\/journal.pone.0184568","volume":"12","author":"A Patoine","year":"2017","unstructured":"Patoine, A., Husseini, A., Kasaai, B., Gaumond, M. H. & Moffatt, P. The osteogenic cell surface marker BRIL\/IFITM5 is dispensable for bone development and homeostasis in mice. PLoS ONE 12, e0184568 (2017).","journal-title":"PLoS ONE"},{"key":"32587_CR26","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1128\/JVI.03416-14","volume":"89","author":"M Xie","year":"2015","unstructured":"Xie, M. et al. Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment. J. Virol. 89, 3049\u20133061 (2015).","journal-title":"J. Virol."},{"key":"32587_CR27","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1084\/jem.20112675","volume":"209","author":"MM Meredith","year":"2012","unstructured":"Meredith, M. M. et al. Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J. Exp. Med. 209, 1153\u20131165 (2012).","journal-title":"J. Exp. Med."},{"key":"32587_CR28","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1073\/pnas.0400525101","volume":"101","author":"K Tabeta","year":"2004","unstructured":"Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516\u20133521 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32587_CR29","doi-asserted-by":"publisher","first-page":"5799","DOI":"10.4049\/jimmunol.180.9.5799","volume":"180","author":"N Zucchini","year":"2008","unstructured":"Zucchini, N. et al. Cutting edge: overlapping functions of TLR7 and TLR9 for innate defense against a herpesvirus infection. J. Immunol. 180, 5799\u20135803 (2008).","journal-title":"J. Immunol."},{"key":"32587_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S1097-2765(00)80136-7","volume":"2","author":"R Medzhitov","year":"1998","unstructured":"Medzhitov, R. et al. MyD88 is an adaptor protein in the hToll\/IL-1 receptor family signaling pathways. Mol. Cell 2, 253\u2013258 (1998).","journal-title":"Mol. Cell"},{"key":"32587_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/eji.202048706","volume":"51","author":"D Wellington","year":"2021","unstructured":"Wellington, D. et al. IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans. Eur. J. Immunol. 51, 742\u2013745 (2021).","journal-title":"Eur. J. Immunol."},{"key":"32587_CR32","doi-asserted-by":"crossref","unstructured":"Forbester, J. L. et al. IRF5 promotes influenza virus-induced inflammatory responses in human induced pluripotent stem cell-derived myeloid cells and murine models. J. Virol. 94, e00121-20 (2020).","DOI":"10.1128\/JVI.00121-20"},{"key":"32587_CR33","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1128\/JVI.77.8.4588-4596.2003","volume":"77","author":"T Compton","year":"2003","unstructured":"Compton, T. et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77, 4588\u20134596 (2003).","journal-title":"J. Virol."},{"key":"32587_CR34","doi-asserted-by":"publisher","first-page":"7094","DOI":"10.4049\/jimmunol.177.10.7094","volume":"177","author":"KW Boehme","year":"2006","unstructured":"Boehme, K. W., Guerrero, M. & Compton, T. Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol. 177, 7094\u20137102 (2006).","journal-title":"J. Immunol."},{"key":"32587_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24817-y","volume":"12","author":"C Prelli Bozzo","year":"2021","unstructured":"Prelli Bozzo, C. et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat. Commun. 12, 4584 (2021).","journal-title":"Nat. Commun."},{"key":"32587_CR36","doi-asserted-by":"publisher","first-page":"e106501","DOI":"10.15252\/embj.2020106501","volume":"40","author":"G Shi","year":"2021","unstructured":"Shi, G. et al. Opposing activities of IFITM proteins in SARS-CoV-2 infection. EMBO J. 40, e106501 (2021).","journal-title":"EMBO J."},{"key":"32587_CR37","doi-asserted-by":"crossref","unstructured":"Winstone, H. et al. The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type I interferon and IFITM2. J. Virol. 95, e02422-20 (2021).","DOI":"10.1128\/JVI.02422-20"},{"key":"32587_CR38","doi-asserted-by":"crossref","unstructured":"Zani, A. et al. Interferon-induced transmembrane protein 3 (IFITM3) limits lethality of SARS-CoV-2 in mice. bioRxiv (2021).","DOI":"10.1101\/2021.12.22.473914"},{"key":"32587_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41590-019-0323-3","volume":"20","author":"P Hubel","year":"2019","unstructured":"Hubel, P. et al. A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape. Nat. Immunol. 20, 493\u2013502 (2019).","journal-title":"Nat. Immunol."},{"key":"32587_CR40","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022\u20133040.e3028 (2021).","journal-title":"Cell"},{"key":"32587_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0962-8924(03)00035-7","volume":"13","author":"T Oertle","year":"2003","unstructured":"Oertle, T. & Schwab, M. E. Nogo and its paRTNers. Trends Cell Biol. 13, 187\u2013194 (2003).","journal-title":"Trends Cell Biol."},{"key":"32587_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/srep35969","volume":"6","author":"O R\u00e4m\u00f6","year":"2016","unstructured":"R\u00e4m\u00f6, O. et al. NOGO-A\/RTN4A and NOGO-B\/RTN4B are simultaneously expressed in epithelial, fibroblast and neuronal cells and maintain ER morphology. Sci. Rep. 6, 35969 (2016).","journal-title":"Sci. Rep."},{"key":"32587_CR43","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000456094","volume":"41","author":"Y Zhu","year":"2017","unstructured":"Zhu, Y. et al. Nogo-B facilitates LPS-mediated immune responses by up-regulation of TLR4-signaling in macrophage RAW264.7. Cell Physiol. Biochem. 41, 274\u2013285 (2017).","journal-title":"Cell Physiol. Biochem."},{"key":"32587_CR44","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.4049\/jimmunol.1402006","volume":"194","author":"T Kimura","year":"2015","unstructured":"Kimura, T. et al. Endoplasmic protein Nogo-B (RTN4-B) interacts with GRAMD4 and regulates TLR9-mediated innate immune responses. J. Immunol. 194, 5426\u20135436 (2015).","journal-title":"J. Immunol."},{"key":"32587_CR45","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1080\/15384101.2015.1044187","volume":"14","author":"DG Ahn","year":"2015","unstructured":"Ahn, D. G. et al. Ras transformation results in cleavage of reticulon protein Nogo-B that is associated with impairment of IFN response. Cell Cycle 14, 2301\u20132310 (2015).","journal-title":"Cell Cycle"},{"key":"32587_CR46","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/ni.1792","volume":"10","author":"R Barbalat","year":"2009","unstructured":"Barbalat, R., Lau, L., Locksley, R. M. & Barton, G. M. Toll-like receptor 2 on inflammatory monocytes induces type I interferon in response to viral but not bacterial ligands. Nat. Immunol. 10, 1200\u20131207 (2009).","journal-title":"Nat. Immunol."},{"key":"32587_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1189\/jlb.0907656","volume":"84","author":"NJ Nilsen","year":"2008","unstructured":"Nilsen, N. J. et al. Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36. J. Leukoc. Biol. 84, 280\u2013291 (2008).","journal-title":"J. Leukoc. Biol."},{"key":"32587_CR48","doi-asserted-by":"publisher","first-page":"e10250","DOI":"10.1371\/journal.pone.0010250","volume":"5","author":"N Dietrich","year":"2010","unstructured":"Dietrich, N., Lienenklaus, S., Weiss, S. & Gekara, N. O. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE 5, e10250 (2010).","journal-title":"PLoS ONE"},{"key":"32587_CR49","doi-asserted-by":"publisher","first-page":"e80743","DOI":"10.1371\/journal.pone.0080743","volume":"8","author":"KJ Brandt","year":"2013","unstructured":"Brandt, K. J., Fickentscher, C., Kruithof, E. K. & de Moerloose, P. TLR2 ligands induce NF-\u03baB activation from endosomal compartments of human monocytes. PLoS ONE 8, e80743 (2013).","journal-title":"PLoS ONE"},{"key":"32587_CR50","doi-asserted-by":"publisher","first-page":"31002","DOI":"10.1074\/jbc.M602794200","volume":"281","author":"M Triantafilou","year":"2006","unstructured":"Triantafilou, M. et al. Membrane sorting of toll-like receptor (TLR)\u22122\/6 and TLR2\/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281, 31002\u201331011 (2006).","journal-title":"J. Biol. Chem."},{"key":"32587_CR51","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.chembiol.2017.05.022","volume":"24","author":"T Oosenbrug","year":"2017","unstructured":"Oosenbrug, T., van de Graaff, M. J., Ressing, M. E. & van Kasteren, S. I. Chemical tools for studying TLR signaling dynamics. Cell Chem. Biol. 24, 801\u2013812 (2017).","journal-title":"Cell Chem. Biol."},{"key":"32587_CR52","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/s41589-019-0262-1","volume":"15","author":"W Dejonghe","year":"2019","unstructured":"Dejonghe, W. et al. Disruption of endocytosis through chemical inhibition of clathrin heavy chain function. Nat. Chem. Biol. 15, 641\u2013649 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"32587_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nri.2016.116","volume":"17","author":"T Worbs","year":"2017","unstructured":"Worbs, T., Hammerschmidt, S. I. & F\u00f6rster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 17, 30\u201348 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"32587_CR54","doi-asserted-by":"publisher","first-page":"40882","DOI":"10.1074\/jbc.M400466200","volume":"279","author":"M Triantafilou","year":"2004","unstructured":"Triantafilou, M. et al. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279, 40882\u201340889 (2004).","journal-title":"J. Biol. Chem."},{"key":"32587_CR55","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.ymthe.2018.05.026","volume":"26","author":"GP Pathak","year":"2018","unstructured":"Pathak, G. P. et al. RTN4 knockdown dysregulates the AKT pathway, destabilizes the cytoskeleton, and enhances paclitaxel-induced cytotoxicity in cancers. Mol. Ther. 26, 2019\u20132033 (2018).","journal-title":"Mol. Ther."},{"key":"32587_CR56","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.3934","volume":"21","author":"A Cantalupo","year":"2015","unstructured":"Cantalupo, A. et al. Nogo-B regulates endothelial sphingolipid homeostasis to control vascular function and blood pressure. Nat. Med. 21, 1028\u20131037 (2015).","journal-title":"Nat. Med."},{"key":"32587_CR57","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nm1020","volume":"10","author":"L Acevedo","year":"2004","unstructured":"Acevedo, L. et al. A new role for Nogo as a regulator of vascular remodeling. Nat. Med. 10, 382\u2013388 (2004).","journal-title":"Nat. Med."},{"key":"32587_CR58","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.cell.2005.11.047","volume":"124","author":"GK Voeltz","year":"2006","unstructured":"Voeltz, G. K., Prinz, W. A., Shibata, Y., Rist, J. M. & Rapoport, T. A. A class of membrane proteins shaping the tubular endoplasmic reticulum. Cell 124, 573\u2013586 (2006).","journal-title":"Cell"},{"key":"32587_CR59","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nm1088","volume":"10","author":"W He","year":"2004","unstructured":"He, W. et al. Reticulon family members modulate BACE1 activity and amyloid-beta peptide generation. Nat. Med. 10, 959\u2013965 (2004).","journal-title":"Nat. Med."},{"key":"32587_CR60","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1038\/emboj.2011.147","volume":"30","author":"KD Harrison","year":"2011","unstructured":"Harrison, K. D. et al. Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation. EMBO J. 30, 2490\u20132500 (2011).","journal-title":"EMBO J."},{"key":"32587_CR61","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.1073\/pnas.0602427103","volume":"103","author":"RQ Miao","year":"2006","unstructured":"Miao, R. Q. et al. Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc. Natl Acad. Sci. USA 103, 10997\u201311002 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32587_CR62","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1126\/science.1161151","volume":"322","author":"JK Atwal","year":"2008","unstructured":"Atwal, J. K. et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322, 967\u2013970 (2008).","journal-title":"Science"},{"key":"32587_CR63","doi-asserted-by":"publisher","first-page":"18026","DOI":"10.1074\/jbc.M110.208108","volume":"286","author":"EA Huebner","year":"2011","unstructured":"Huebner, E. A., Kim, B. G., Duffy, P. J., Brown, R. H. & Strittmatter, S. M. A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1. J. Biol. Chem. 286, 18026\u201318036 (2011).","journal-title":"J. Biol. Chem."},{"key":"32587_CR64","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/35053072","volume":"409","author":"AE Fournier","year":"2001","unstructured":"Fournier, A. E., GrandPre, T. & Strittmatter, S. M. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409, 341\u2013346 (2001).","journal-title":"Nature"},{"key":"32587_CR65","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1074\/jbc.M609797200","volume":"282","author":"J Laur\u00e9n","year":"2007","unstructured":"Laur\u00e9n, J. et al. Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J. Biol. Chem. 282, 5715\u20135725 (2007).","journal-title":"J. Biol. Chem."},{"key":"32587_CR66","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1126\/science.1187029","volume":"329","author":"M Sasai","year":"2010","unstructured":"Sasai, M., Linehan, M. M. & Iwasaki, A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329, 1530\u20131534 (2010).","journal-title":"Science"},{"key":"32587_CR67","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/ni1569","volume":"9","author":"JC Kagan","year":"2008","unstructured":"Kagan, J. C. et al. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9, 361\u2013368 (2008).","journal-title":"Nat. Immunol."},{"key":"32587_CR68","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.4049\/jimmunol.1501268","volume":"195","author":"T Petnicki-Ocwieja","year":"2015","unstructured":"Petnicki-Ocwieja, T., Kern, A., Killpack, T. L., Bunnell, S. C. & Hu, L. T. Adaptor protein-3-mediated trafficking of TLR2 ligands controls specificity of inflammatory responses but not adaptor complex assembly. J. Immunol. 195, 4331\u20134340 (2015).","journal-title":"J. Immunol."},{"key":"32587_CR69","doi-asserted-by":"crossref","unstructured":"Groft, S. G., Nagy, N., Boom, W. H. & Harding, C. V. Toll-like receptor 2-Tpl2-dependent ERK signaling drives inverse interleukin 12 regulation in dendritic cells and macrophages. Infect. Immun. 89, e00323-20 (2020).","DOI":"10.1128\/IAI.00323-20"},{"key":"32587_CR70","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","volume":"139","author":"AL Brass","year":"2009","unstructured":"Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243\u20131254 (2009).","journal-title":"Cell"},{"key":"32587_CR71","doi-asserted-by":"crossref","unstructured":"Silvin, A. et al. Constitutive resistance to viral infection in human CD141. Sci. Immunol. 2, eaai8071 (2017).","DOI":"10.1126\/sciimmunol.aai8071"},{"key":"32587_CR72","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"RC Group","year":"2021","unstructured":"Group, R. C. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637\u20131645 (2021).","journal-title":"Lancet"},{"key":"32587_CR73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0896-6273(03)00147-8","volume":"38","author":"JE Kim","year":"2003","unstructured":"Kim, J. E., Li, S., GrandPre, T., Qiu, D. & Strittmatter, S. M. Axon regeneration in young adult mice lacking Nogo-A\/B. Neuron 38, 187\u2013199 (2003).","journal-title":"Neuron"},{"key":"32587_CR74","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/35099560","volume":"413","author":"L Alexopoulou","year":"2001","unstructured":"Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell, R. A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413, 732\u2013738 (2001).","journal-title":"Nature"},{"key":"32587_CR75","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1073\/pnas.0400937101","volume":"101","author":"JM Lund","year":"2004","unstructured":"Lund, J. M. et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl Acad. Sci. USA 101, 5598\u20135603 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32587_CR76","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740\u2013745 (2000).","journal-title":"Nature"},{"key":"32587_CR77","doi-asserted-by":"publisher","first-page":"e1004641","DOI":"10.1371\/journal.ppat.1004641","volume":"11","author":"G Stack","year":"2015","unstructured":"Stack, G. et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 11, e1004641 (2015).","journal-title":"PLoS Pathog."},{"key":"32587_CR78","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1172\/JCI42955","volume":"120","author":"RJ Stanton","year":"2010","unstructured":"Stanton, R. J. et al. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120, 3191\u20133208 (2010).","journal-title":"J. Clin. Invest."},{"key":"32587_CR79","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1099\/vir.0.83286-0","volume":"89","author":"C Sinzger","year":"2008","unstructured":"Sinzger, C. et al. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40\/E. J. Gen. Virol. 89, 359\u2013368 (2008).","journal-title":"J. Gen. Virol."},{"key":"32587_CR80","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5694\/mja2.50569","volume":"212","author":"L Caly","year":"2020","unstructured":"Caly, L. et al. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med. J. Aust. 212, 459\u2013462 (2020).","journal-title":"Med. J. Aust."},{"key":"32587_CR81","doi-asserted-by":"crossref","unstructured":"Fielding, C. A. et al. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies. Elife 11, e74489 (2022).","DOI":"10.7554\/eLife.74489"},{"key":"32587_CR82","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/imm.13368","volume":"164","author":"S Dimonte","year":"2021","unstructured":"Dimonte, S. et al. Optimal CD8. Immunology 164, 279\u2013291 (2021).","journal-title":"Immunology"},{"key":"32587_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymeth.2015.11.012","volume":"96","author":"A Leha","year":"2016","unstructured":"Leha, A. et al. A high-content platform to characterise human induced pluripotent stem cell lines. Methods 96, 85\u201396 (2016).","journal-title":"Methods"},{"key":"32587_CR84","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3389\/fimmu.2017.01935","volume":"8","author":"P Sachamitr","year":"2017","unstructured":"Sachamitr, P., Leishman, A. J., Davies, T. J. & Fairchild, P. J. Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141. Front. Immunol. 8, 1935 (2017).","journal-title":"Front. Immunol."},{"key":"32587_CR85","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.chom.2014.07.005","volume":"16","author":"RJ Stanton","year":"2014","unstructured":"Stanton, R. J. et al. HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition of infected cells. Cell Host Microbe 16, 201\u2013214 (2014).","journal-title":"Cell Host Microbe"},{"key":"32587_CR86","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367\u20131372 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32587-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32587-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T16:23:59Z","timestamp":1662654239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32587-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32587"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32587-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,8]]},"assertion":[{"value":"23 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal studies were performed at Cardiff University (Heath Park research support facility) under UK Home Office Project License number P7867DADD, as approved by the UK Home Office, London, United Kingdom. Written consent was obtained for the use of cell lines for the HipSci project from healthy volunteers. Ethical approval was granted by the National Research Ethics Service (NRES) Research Ethics Committee Yorkshire and The Humber-Leeds West, under reference number 15\/YH\/0391.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"5294"}}